Annual Shareholders Equity
$53.44 M
+$31.83 M+147.33%
December 31, 2023
Summary
- As of February 27, 2025, PBYI annual stockholders equity is $53.44 million, with the most recent change of +$31.83 million (+147.33%) on December 31, 2023.
- During the last 3 years, PBYI annual shareholders equity has risen by +$59.39 million (+998.03%).
- PBYI annual shareholders equity is now -74.53% below its all-time high of $209.82 million, reached on December 31, 2016.
Performance
PBYI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$71.09 M
+$22.58 M+46.55%
September 30, 2024
Summary
- As of February 27, 2025, PBYI quarterly stockholders equity is $71.09 million, with the most recent change of +$22.58 million (+46.55%) on September 30, 2024.
- Over the past year, PBYI quarterly shareholders equity has increased by +$32.35 million (+83.49%).
- PBYI quarterly shareholders equity is now -76.64% below its all-time high of $304.34 million, reached on March 31, 2015.
Performance
PBYI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PBYI Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +147.3% | +83.5% |
| 3 y3 years | +998.0% | +260.2% |
| 5 y5 years | +55.8% | +260.2% |
PBYI Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2284.9% | at high | +3006.3% |
| 5 y | 5-year | at high | +998.0% | at high | +750.9% |
| alltime | all time | -74.5% | +998.0% | -76.6% | +750.9% |
Puma Biotechnology Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.09 M(+46.5%) |
| Jun 2024 | - | $48.51 M(-4.9%) |
| Mar 2024 | - | $50.98 M(-4.6%) |
| Dec 2023 | $53.44 M(+147.3%) | $53.44 M(+37.9%) |
| Sep 2023 | - | $38.74 M(+27.4%) |
| Jun 2023 | - | $30.40 M(+17.6%) |
| Mar 2023 | - | $25.85 M(+19.6%) |
| Dec 2022 | $21.61 M(-983.4%) | $21.61 M(-2.5%) |
| Sep 2022 | - | $22.16 M(+12.2%) |
| Jun 2022 | - | $19.74 M(+176.2%) |
| Mar 2022 | - | $7.14 M(-392.1%) |
| Dec 2021 | -$2.45 M(-58.9%) | -$2.45 M(-77.6%) |
| Sep 2021 | - | -$10.92 M(-137.1%) |
| Jun 2021 | - | $29.47 M(+79.3%) |
| Mar 2021 | - | $16.44 M(-376.2%) |
| Dec 2020 | -$5.95 M(-134.1%) | -$5.95 M(+1213.7%) |
| Sep 2020 | - | -$453.00 K(-101.9%) |
| Jun 2020 | - | $23.40 M(+149.6%) |
| Mar 2020 | - | $9.38 M(-46.3%) |
| Dec 2019 | $17.46 M(-49.1%) | $17.46 M(+1.6%) |
| Sep 2019 | - | $17.18 M(-21.1%) |
| Jun 2019 | - | $21.77 M(-49.9%) |
| Mar 2019 | - | $43.47 M(+26.7%) |
| Dec 2018 | $34.31 M(-35.6%) | $34.31 M(-25.3%) |
| Sep 2018 | - | $45.91 M(+19.9%) |
| Jun 2018 | - | $38.30 M(-33.3%) |
| Mar 2018 | - | $57.46 M(+7.8%) |
| Dec 2017 | $53.30 M(-74.6%) | $53.30 M(-32.7%) |
| Sep 2017 | - | $79.17 M(-34.1%) |
| Jun 2017 | - | $120.11 M(-28.2%) |
| Mar 2017 | - | $167.39 M(-20.2%) |
| Dec 2016 | $209.82 M | $209.82 M(+130.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $91.15 M(-28.3%) |
| Jun 2016 | - | $127.08 M(-23.0%) |
| Mar 2016 | - | $164.94 M(-19.9%) |
| Dec 2015 | $206.01 M(+76.0%) | $206.01 M(-15.9%) |
| Sep 2015 | - | $244.84 M(-10.9%) |
| Jun 2015 | - | $274.78 M(-9.7%) |
| Mar 2015 | - | $304.34 M(+160.0%) |
| Dec 2014 | $117.05 M(+39.4%) | $117.05 M(-17.3%) |
| Sep 2014 | - | $141.60 M(-15.2%) |
| Jun 2014 | - | $167.04 M(-16.0%) |
| Mar 2014 | - | $198.79 M(+136.7%) |
| Dec 2013 | $83.99 M(-34.8%) | $83.99 M(-11.4%) |
| Sep 2013 | - | $94.76 M(-11.5%) |
| Jun 2013 | - | $107.03 M(-9.5%) |
| Mar 2013 | - | $118.28 M(-8.2%) |
| Dec 2012 | $128.91 M(+137.1%) | $128.91 M(+1331.9%) |
| Sep 2012 | - | $9.00 M(-67.9%) |
| Jun 2012 | - | $28.04 M(-34.2%) |
| Mar 2012 | - | $42.60 M(-21.7%) |
| Dec 2011 | $54.37 M(>+9900.0%) | $54.37 M(>+9900.0%) |
| Sep 2011 | - | $0.00(-100.0%) |
| Jun 2011 | - | -$1500.00(-31.8%) |
| Mar 2011 | - | -$2200.00(-540.0%) |
| Dec 2010 | $500.00(+400.0%) | $500.00(-76.2%) |
| Sep 2010 | - | $2100.00(+16.7%) |
| Jun 2010 | - | $1800.00(>+9900.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $100.00(-104.5%) | $100.00(0.0%) |
| Sep 2009 | - | $100.00(-50.0%) |
| Jun 2009 | - | $200.00(-150.0%) |
| Mar 2009 | - | -$400.00(-81.8%) |
| Dec 2008 | -$2200.00 | -$2200.00 |
FAQ
- What is Puma Biotechnology annual stockholders equity?
- What is the all time high annual shareholders equity for Puma Biotechnology?
- What is Puma Biotechnology annual shareholders equity year-on-year change?
- What is Puma Biotechnology quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Puma Biotechnology?
- What is Puma Biotechnology quarterly shareholders equity year-on-year change?
What is Puma Biotechnology annual stockholders equity?
The current annual shareholders equity of PBYI is $53.44 M
What is the all time high annual shareholders equity for Puma Biotechnology?
Puma Biotechnology all-time high annual stockholders equity is $209.82 M
What is Puma Biotechnology annual shareholders equity year-on-year change?
Over the past year, PBYI annual stockholders equity has changed by +$31.83 M (+147.33%)
What is Puma Biotechnology quarterly stockholders equity?
The current quarterly shareholders equity of PBYI is $71.09 M
What is the all time high quarterly shareholders equity for Puma Biotechnology?
Puma Biotechnology all-time high quarterly stockholders equity is $304.34 M
What is Puma Biotechnology quarterly shareholders equity year-on-year change?
Over the past year, PBYI quarterly stockholders equity has changed by +$32.35 M (+83.49%)